Literature DB >> 9017778

Suspected acute interstitial nephritis induced by piperacillin-tazobactam.

M W Pill1, C V O'Neill, M M Chapman, A K Singh.   

Abstract

A 51-year-old woman developed an acute onset of renal dysfunction accompanied by rash, lumbar pain, arthralgias, fever, eosinophiluria, and an elevated serum creatinine after 6 days of intravenous piperacillin-tazobactam therapy. On discontinuing piperacillin-tazobactam and after a 21-day course of prednisone, the patient's constitutional symptoms dissipated and her renal function returned to baseline. Acute interstitial nephritis has been reported as an adverse effect of many drugs, including antibiotics, but not, to our knowledge, after piperacillin-tazobactam. The time course of events suggested that piperacillin-tazobactam was the cause of acute interstitial nephritis in this patient.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9017778

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  8 in total

1.  Top Guns: The "Maverick" and "Goose" of Empiric Therapy.

Authors:  Stephen W Davies; Jimmy T Efird; Christopher A Guidry; Zachary C Dietch; Rhett N Willis; Puja M Shah; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2015-10-20       Impact factor: 2.150

2.  The association of acute kidney injury with the concomitant use of vancomycin and piperacillin/tazobactam in children: A systematic review and meta-analysis.

Authors:  Markos Kalligeros; Spyridon A Karageorgos; Fadi Shehadeh; Ioannis M Zacharioudakis; Eleftherios Mylonakis
Journal:  Antimicrob Agents Chemother       Date:  2019-10-07       Impact factor: 5.191

3.  Comparison of teicoplanin versus vancomycin in combination with piperacillin-tazobactam or meropenem for the risk of acute kidney injury.

Authors:  Abdullah Tarık Aslan; Tural Pashayev; Osman Dağ; Murat Akova
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-04-22       Impact factor: 3.267

4.  Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam, Cefepime, or Meropenem.

Authors:  Adam M Blevins; Jennifer N Lashinsky; Craig McCammon; Marin Kollef; Scott Micek; Paul Juang
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

Review 5.  Acute post streptococcal interstitial nephritis in an adult and review of the literature.

Authors:  T S Dharmarajan; J Yoo; R O Russell; Y A Boateng
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

Review 6.  Drug-induced impairment of renal function.

Authors:  George Sunny Pazhayattil; Anushree C Shirali
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-12-12

Review 7.  Piperacillin-Tazobactam Plus Vancomycin-Associated Acute Kidney Injury in Adults: Can Teicoplanin or Other Antipseudomonal Beta-Lactams Be Remedies?

Authors:  Abdullah Tarık Aslan; Murat Akova
Journal:  Healthcare (Basel)       Date:  2022-08-20

8.  Association of vancomycin plus piperacillin-tazobactam with early changes in creatinine versus cystatin C in critically ill adults: a prospective cohort study.

Authors:  Nuala J Meyer; Michael G S Shashaty; Todd A Miano; Sean Hennessy; Wei Yang; Thomas G Dunn; Ariel R Weisman; Oluwatosin Oniyide; Roseline S Agyekum; Alexandra P Turner; Caroline A G Ittner; Brian J Anderson; F Perry Wilson; Raymond Townsend; John P Reilly; Heather M Giannini; Christopher V Cosgriff; Tiffanie K Jones
Journal:  Intensive Care Med       Date:  2022-07-14       Impact factor: 41.787

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.